2022 Liver Cancer News

December 2022

TACE + Apatinib: A potential New Strategy for Intermediate/Advanced HCC?

Novel AI Blood Test DELFI May Help Detect Liver Cancer

Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer

Liver Cancer: Warning Signs and Symptoms; How to Prevent its Occurrence

Liver Cancer and Treatment with Dr. Hesham Gayar

Urine Test for Liver Cancer a Step Closer After Glasgow Scientists' Discovery

The Expansion of Treatment in the Firstline Setting of HCC

Overview of Hepatocellular Carcinoma Risk Factors

Nivolumab Plus Cabozantinib With or Without Ipilimumab in Advanced Hepatocellular Carcinoma

The VA Launches Largest-Ever Trial on Screening Methods for Liver Cancer

Imfinzi plus Imjudo recommended for approval in the EU by CHMP for the treatment of advanced liver and lung cancers

Adagene, Roche announce trial collaboration for HCC combination therapy

Diabetes and Liver Disease: What Is the Relationship?

Liver cancer, low HDL cholesterol and steatosis can predict it – Medicine

Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer

TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research Developments

Liver Cancer Exacts High Financial Toll on Older Adults

Study identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy

Dr. Singal on the FDA Approval of Durvalumab With Tremelimumab in Unresectable HCC

LEAP-002 Trial of Lenvatinib in uHCC Misses Co-Primary End Points

HKUMed discovers novel immunotherapeutic target against hepatocellular carcinoma first time in world

A Phase III Study of Durvalumab, Tremelimumab, and Transarterial Chemoembolization (TACE) Given with or without Lenvatinib Compared to TACE Alone in People with Localized Liver Cancer

Study shows how dietary saturated/trans fats promote liver tumorigenesis

Cell-Free DNA Fragmentome Analysis Can Be Used to Detect Hepatocellular Carcinoma

Black nightshade leaves decoction aka Raatrani leaves kadha can cure liver cancer, claims research

Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial

‘Get help right away!’: A specific type of pain is 'clearest' sign of a 'strained' liver

Hepatocarcinoma: Symptoms, Diagnosis And Treatment Of Liver Cancer

Liver Cancer Treatment Gets More Effective: New Options Shows Promise

Consumer Health: Treating liver cancer

Researchers use metabolomics to discover potential biomarkers of hepatocellular carcinoma

Natural products for prevention, treatment of liver cancer

Robotic Liver Resection Safe Alternative to Open Surgery in HCC

Tremelimumab Plus Durvalumab Receives Go-ahead for Treatment of HCC

Novel DELFI AI Blood Test May Aid in Detecting Hepatocellular Carcinoma

November 2022

A New Method for Conducting a Liquid Biopsy for Liver Cancer

Robotic Resection Cuts Perioperative Morbidity with Liver Cancer

Married HCC Patients Have Better Overall Survival

Ghassan K. Abou-Alfa, MD, Discusses Next Steps in Researching Unresectable HCC

Hepatocellular Carcinoma Screening in Blood-Based Biomarkers

Study Shows How Liver Cancer Cells Go Astray

Entecavir Plus Traditional Chinese Medicine Cuts HCC Risk in CHB

Diagnosed With Liver Cancer? Baseball Legend Bernie Williams Shares Tips on Liver Health

Johns Hopkins Cell-free DNA Blood Test Detects 80% of Liver Cancers in Study

Melissa L. Johnson, MD, on the Approval of Tremelimumab Plus Durvalumab/Chemo in NSCLC

Liver Disease and Why It’s Concern for Asian Americans and Pacific Islanders

MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma

UCLA Researchers Develop New Method for Early Cancer Detection

HCC Treatment with CLDN1 Specific Antibodies Suppresses Carcinogenic Signaling and Reprograms the Tumor Microenvironment

Ghassan K. Abou-Alfa, MD, Spotlights Patients With Unresectable HCC Who May Best Benefit From Tremelimumab/Durvalumab

Safety and Efficacy-Associated Risk Calculator for Hepatocellular Carcinoma in The Elderly After Resection (SEARCHER)

Ipsen’s Cabozantinib Receives NICE Approval for Advanced Hepatocellular Carcinoma

Liver Cirrhosis Can Lead to Liver Cancer! Here’s How

Dr. Jeff Geschwind, is Now Offering Cutting Edge Treatment for Liver Cancer

Discussing the LEAP-002 Trial of Lenvatinib Plus Pembrolizumab in HCC

FDA-Approved Treatment ‘Great Positive Result in the Right Direction’ for Advanced HCC, Yet Unmet Needs Remain

Medivir Presents New Data on Additive Efficacy of Fostrox in Combination with Anti-PD1 in Nonclinical Tumor Models at the SITC Immunotherapy Conference

Improved Culturally Competent Care may Boost Early Detection in ‘Late-stage HCC Hotspots’

Protein Inhibitor Could be New Treatment for Liver Cancer

Small Study of Experimental Drug to Treat Liver Cancer Shows Evidence of Activity With Manageable Side Effects

Geneos Therapeutics Announces Positive Clinical Data for Personalized Therapeutic Cancer Vaccines in Ongoing Liver Cancer Trial

Ghassan K. Abou-Alfa, MD, Discusses Importance of Treatment Accessibility in Unresectable HCC

Scientists Find Strong Evidence for Testing VCU-manufactured Drug in Liver Cancer

FDA Grants Orphan Drug Designation to OTX-2002 for Hepatocellular Carcinoma

An Abundance of Therapies for Early- and Late-Line HCC

SBRT Proposed as Standard Treatment Option for Advanced Hepatocellular Carcinoma

Consumer Health: Treating Liver Cancer

Ghassan K. Abou-Alfa, MD, Highlights Approval of Tremelimumab and Durvalumab in Unresectable HCC

October 2022

How to Manage Eating Problems During Cancer Treatment

What To Know About Liver Cancer

Atezolizumab Anti-drug Antibodies Worsen Survival in Hepatocellular Carcinoma

Risk of HCC Warrants Careful Surveillance in People With Primary Biliary Cholangitis

Delfi Diagnostics to Present Proof-of-concept Data for Liver Cancer Detection Platform

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Antidrug Antibodies Against Atezolizumab Associated With Poor Outcomes in HCC

Interpreting Results From New and Previous Trials of Lenvatinib in HCC

RZNOMICS Inc. Received FDA Approval to Initiate Clinical Development of Trans-splicing Ribozyme-based RNA Editing Technology in Liver Cancer Patients

Charity Sounds Alarm Over ‘Worrying Rise’ in Liver Cancer

Tenofovir Alafenamide Reduces Liver Stiffness in CHB patients

Liver Cancer Awareness Month: A Decade of Progress and Hope in Hepatocellular Carcinoma

Glympse to Present Data Demonstrating Sensitive Detection of Hepatocellular Carcinoma at AASLD The Liver Meeting 2022

FDA Approves Tremelimumab, Durvalumab Combination for Unresectable Liver Cancer

Radiation Therapy Extends Progression-free Survival in Patients with Hepatocellular Carcinoma

AstraZeneca Says Imjudo-Imfinzi Combination Approved for Advanced Liver Cancer in US

Helping the Liver Regenerate Itself Could Give Patients an Option Besides Waiting for Transplant

Study Points Toward New Ways to Prevent Liver Cancer

Successful Hepatitis C Treatment Improves Liver Cancer Outcomes

FDA Grants Fast Track Designation to TTI-101 for Advanced Hepatocellular Carcinoma

Gene Expression Signatures Are Analyzed for Biomarkers of Response in HCC

Regorafenib Then Nivolumab Sequence Is Tolerable After First-Line HCC Treatment

Liver Cancer Awareness Month: How UW Health is Working to Fight the Deadly Cancer

Increased Mitochondria and Lipid Turnover Reduces Risk for Liver Cancer

The Link Between Liver Cancer & Hepatitis

Local Organization Provides Support During Liver Cancer Awareness Month

Elevar Therapeutics Announces Positive Pre-NDA Meeting for Rivoceranib Combination With Camrelizumab as Hepatocellular Carcinoma Treatment Option

Diets High in Processed Fiber May Increase Cancer Risk

Lilly, Innovent's Cyramza Gets Approval in China to Treat Liver Cancer

Global Rates of Liver Cancer Could Rise by More Than 50 Percent by 2040

Press news Biocartis Group NV: Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer Patients

Treatment Approaches for Advanced Hepatocellular Carcinoma: Observations From EMSO Congress 2022

The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma

Liver Cancer Cases and Deaths Projected to Rise by More Than 55% by 2040

Clinical Trial Results Allude to New Options for Patients With HCC

Singapore Pumps in SGD19.2 M for Novel Liver Cancer Treatment Trial

Mechanism Cancer Cells Use To Spread to the Liver Discovered

Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Structural Variations that OGM Detected in Liver Cancer

Study Shows Synergistic Association Between Genetic and Behavioral Risks for Liver Disease

October is National Liver Awareness Month, Are You at Risk?

Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma

Camrelizumab Plus rivoceranib vs Sorafenib as First-line Therapy for Unresectable Hepatocellular Carcinoma: A Randomized, Phase 3 Trial

Early- and Intermediate-Stage HCC Treatment Landscape

September 2022

Multi-site Clinical Trial to Assess Novel Liver Cancer Treatment with SGD19.2 Million Industry Support

For Monitoring Purposes, AI-aided MRI Does What Liver Biopsy Does With Less Risk, Lower Cost

Dr Karin Schmitt joins Mursla as Chief Operating Officer

American Liver Foundation Hosts Free Liver Cancer Conference for Patients and Families

Data on Liver Cancer Described by Researchers at National Taiwan University Hospital (Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: a National Study): Oncology – Liver Cancer

Dosing and Toxicity: Management of Lenvatinib for Patients With Advanced HCC

Diets Rich in Refined Fiber May Increase Liver Cancer Risk in Some Individuals

Study Offers Support for Increasing the Use of Living Donor Liver Transplantation in Western Countries

Properative Inflamatory Markers Prognostic Indicators After Liver Resection

Liver Cancer Can Cause Pain Around Your Right Shoulder Blade

Certain Patients With Cured Hepatitis C Virus Infection Still Face Risks for Hepatocellular Carcinoma

LEAP-002 Trial of Lenvatinib/Pembrolizumab Combo Misses Key End Points in uHCC

Diets Rich in Refined Fiber May Increase Liver Cancer Risk in Some Individuals

What Are the Ways to Avoid Liver Cancer?

Singapore Awards NRF Grant to Develop Novel Therapies for Liver Cancer

Lenvatinib Dose Escalation Is Associated With Favorable Outcomes in Patients with HCC

Metabolic Syndrome Leads to Worse Outcomes For Patients With HBV-Related HCC

First-Line Pembrolizumab Failed to Improve PFS, OS in Advanced HCC

People of Mexican Descent May Have a Higher Risk of Liver Cancer With Each Generation

HistoSonics Announces Published Results of Phase I Liver Tumor Trial

Immunotherapy Drives First-line Systemic Treatment for Advanced HCC

Sept Research Explores New Treatments and Combinations for Hepatocellular Carcinoma

Real-World Data Show TRAEs Associated With Improved Survival With Atezolizumab plus Bevacizumab in HCC

Sirtex Medical Secures Positive Approval of SIR-Spheres® Y-90 Resin Microspheres for HCC Treatment in Brazil

Addition of Pembrolizumab to Lenvatinib does not Improve OS in Advanced HCC

Nanomedicine for Liver Cancer Developed by Amrita Researchers Gets US, Aus Patent

Lenvima Plus Keytruda Disappoints in Unresectable Hepatocellular Cancer

Novartis Announces Tislelizumab Efficacy Results from Phase 3 Trial

Not Brushing Your Teeth Properly Raises the Risk of Liver Cancer by 75% - Study

Cancer: Three Red Flags in Your Stool That Could be Hinting at ‘Late Stage’ Liver Cancer

LEAP-002 Trial Results Support Use of Lenvatinib Monotherapy in uHCC, Despite Missing Co-Primary End Points

Frontline Tislelizumab Shows Non-Inferior OS vs Sorafenib in Unresectable HCC

Elevar Therapeutics Announces Camrelizumab Plus Rivoceranib Significantly Prolonged Overall Survival and Progression-Free Survival Versus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma During Phase 3 Trial, a Joint Program With Hengrui Pharma

Black Patients With HCC, Those Living in High-Poverty Neighborhoods Have Higher Odds of Experiencing Treatment Delays

Choosing Second-Line Therapy for HCC After Atezolizumab/Bevacizumab

Exposure to Widespread Synthetic Pollutants Linked to Surprising ‘magnitude’ of HCC Risk

Sequential Combo of Regorafenib and Nivolumab Shows Manageable Safety in Sorafenib-Pretreated HCC

The Popular Drink That May Increase Your Risk of Cancer by Almost 80% - It's Not Alcohol

SMC Raises Inoperable Liver Cancer Patients’ Survival Rate Using Radiotherapy

7 Ways You're Ruining Your Liver Without Even Realizing It

Multiparametric MRI Features Can Predict Liver Cancer Recurrence

How Accurate are Contrast-Enhanced Ultrasound Scans for Detecting Hepatocellular Carcinoma?

Hydrogel Improves Safety and Efficacy of Microwave Ablation

Liver Transplantation ‘Remains the Standard of Care’ for HCC Patients, Regardless of Age

Safety-Net Hospital Implements Hepatocellular Carcinoma Screening Program

Cedars-Sinai Team Pioneers Liver Cancer Blood Test

August 2022

Nomograms Predict Risk for Early Death in HCC, May Guide ‘Individualized TAreatment’

Adjuvant Sorafenib After RFA Boosts Survival in Recurrent Hepatocellular Carcinoma

Minimally Invasive Therapy for Liver Cancer Patients a Success

Understanding Liver Cancer in Young Adults: Causes and Prevalence

A Liver Ultrasound: What This Procedure Means

The Evolving Treatment Landscape of HCC

Can-Fite’s Drug Namodenoson Approved for Compassionate Use Treatment of Advanced Liver Cancer Patients in Romania

Using Quantitative Immunohistochemistry in Patients at High Risk for Hepatocellular Cancer

Researchers Uncover New Driver of Carcinogenesis in Liver Cancer

Downstaging HCC to Milan Criteria Prior to Liver Transplant Yield ‘Excellent Outcomes’

Research Roundup: Fat Cell Hormone Slows Liver Tumor Growth and More Research News

Scientists Identify New Driver for Rare Type of Liver Cancer

Most Patients With Cirrhosis Do Not Undergo Hepatocellular Carcinoma Surveillance

Machine Learning Models Predict Hepatocellular Carcinoma Treatment Response

Machine Learning Models Can Predict Posttreatment Recurrence in Patients with Early-stage Hepatocellular Carcinoma

Later-Line IO Therapy for Advanced Hepatocellular Carcinoma

TACE Prolongs PFS and OS in Advanced Hepatocellular Carcinoma

Researchers Identify a Hormone From Fat Cells That Reprogram the Liver Microenvironment and Restrain Tumor Growth in Mice

Warning: Kitchen utensils can increase risk of liver cancer up to 4.5 fold, says study

Nivolumab/Ipilimumab Combo Provides Long-Term Survival Benefit in Advanced HCC After Sorafenib

Single-Agent Pembrolizumab Maintains Survival Benefit in Sorafenib-Pretreated Advanced HCC

NASH ‘fastest growing cause’ of liver cancer death worldwide

Keytruda-Lenvima Combo Fails to Top Lenvima Alone in Patients With Unresectable Liver Cancer

Addition of Transarterial Chemoembolization to Lenvatinib in First-Line Treatment of Advanced Hepatocellular Carcinoma

BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer

Findings of the IMMUTACE Trial in Hepatocellular Carcinoma

Phase 3 trial of tislelizumab in hepatocellular carcinoma meets survival endpoint

Scientists Link ‘Forever Chemical’ Exposure to Development of Liver Cancer

HCC surveillance underused in most patients with cirrhosis; screening improvements needed

Penn Medicine, Philadelphia: Liver Cancer’s Supercharged Metabolism Offers A New Treatment Strategy, Penn Study Suggests

Safety of IBS During Liver Transplantation in Hepatocellular Carcinoma Patients

Racial Disparities Identified in Access to Immunotherapy for Advanced HCC

Hong Kong-led Trials Show Patients with Rare Liver Cancer can Live Longer by Undergoing Combined Treatments

Pembrolizumab Plus Lenvatinib Misses Primary End Points in Unresectable HCC

Automated Care Coordination Tool Improves Timeliness of Liver Cancer Care

Exploring Tislelizumab for Unresectable HCC

Despite Trends Towards PFS, OS Improvement, Pembrolizumab/Lenvatinib Trial in HCC Misses Primary End Points

Pembrolizumab/Lenvatinib Combo Misses Survival End Points in Unresectable HCC

Novel Combination Therapy Developed against Liver Cancer

Frontline Lenvatinib versus Sorafenib Treatment in Advanced HCC

Frontline Therapy for Advanced HCC: Novel Combination Strategies

Study Pinpoints a Three-pronged Approach that Makes Liver Cancer Cells Stop Growing

Hepatocellular Carcinoma in French Polynesia: specificities

Merck and Eisai Provide Update on Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma

Black, Hispanic Patients with Hepatocellular Carcinoma Less Likely to Receive Immunotherapy

Study: Cannabis Users Are 55 Percent Less Likely to Have This Type of Cancer

Treatment to Shrink Liver Cancer Tumors Helps Patients Become Eligible for Potentially Curative Transplant

ICIs Appear Safer Than TKIs for Advanced Hepatocellular Carcinoma

Hope for Older Patients with Liver Cancer

A liver transplant may still be a viable option for older people with liver cancer.

July 2022

What to Know About Liver Transplant Surgery

Hepatitis C Raises Liver Cancer Risk in Men With Hemophilia, Study Says

New Study Shows Hope, Options for Older Patients With Liver Cancer

Role of Hepatitis Status in Selecting Therapy for HCC

This Is the No. 1 Liver Cancer Symptom People Ignore, Doctors Say

Q BioMed Announces Publication of Pre-clinical Research Showing Superior Safety and Efficacy Against Current First Line Therapy of its Drug Candidate Uttroside-B for Liver Cancer

CRISPR Gene Editing May Cause Permanent Damage - Study

Help Prevent Liver Cancer with 7 Simple Steps

Radiation Segmentectomy for Very Early– and Early-Stage Hepatocellular Carcinoma

Might Metformin Protect Against Hepatocellular Carcinoma?

Scientists Now Reveal Why Men Are More Susceptible to Developing Liver Cancer

What to Know About Artificial Liver Support Systems

The Causes of Liver Cancer Are Changing

Prior Decompensation and Older Age Increases HCC Risk Among Cirrhosis Patients After HCV Infection

No Difference in HCC Risk Between Tenofovir, Entecavir for Chronic HBV Infection

Kim and Schwartz Break Down the Role of Radiation Segmentectomy With Y-90 in Early-Stage HCC

Cabozantinib Plus Atezolizumab Improves PFS, Not OS in Hepatocellular Carcinoma

Cabometyx-Tecentriq Combo Bests Nexavar in Controlling Disease, Limiting Progression in Patients With Advanced Liver Cancer

Ultrasound Partially Destroys Cancerous Tumors in Rats

Phase III Trial of Cabozantinib and Atezolizumab vs Sorafenib in Advanced Hepatocellular Carcinoma

113-Gene Signature May Predict Long-Term HCC Risk in NAFLD

p53 in Liver Cancer: The Ultimate Betrayal?

SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG's Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers

Survey Uncovers Barriers To HCC Surveillance

JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma

Assessing the Risk of HCC for Hepatitis B Treatments

June 2022

HistoSonics Hits Enrollment Target en route to FDA Filing for Liver Cancer Therapy

Liver Disease is Reversible with Lifestyle Changes — PCP 

Teclison Announces Publication of Phase 1 Data Demonstrating the Safety and Therapeutic Potential of Tirapazamine Chemoembolization for Patients with Unresectable Liver Cancer

FDA Grants Orphan Drug Designation to Rencofilstat for Hepatocellular Carcinoma

Surface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma

FDA Grants Orphan Drug Designations to VBI, Hepion Cancer Drugs

Ultrasonic subthreshold observations unlikely to become HCC

Omega Therapeutics Announces Submission of Investigational New Drug Application for OTX-2002, an Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma

Yale Liver Center Anticipates Future Advances in Liver Care

New Mechanism in CD47 Blockade Treatment in HCC

Could Lots of Sugary Sodas Raise a Woman's Odds for Liver Cancer?

Targeting Cacropinocytosis May be an Effective Therapeutic Approach for Hepatocellular Carcinoma

U.K.-Based Liver Surgery Scoring System Correlates With U.S. Outcomes

Coffee, Tea, Milk, and Yoghurt May Cut Risk of Hepatocellular Carcinoma

People With Viral Hepatitis Who Drink Alcohol Have Worse Outcomes

A new high-throughput glycoproteomics approach reveals signatures for diagnosis of liver disease

New Machine Learning Algorithm Finds a Gene Signature Characteristic of Tumors

Could gold nanoparticles help treat cancer?

Discovering a New Metabolic Route for Liver Cancer and Paving the Way for New Therapeutic Opportunities

Racial Inequalities in Liver Cancer Deaths Linked to Hepatitis C Treatment

Black, Hispanic Patients with Advanced Liver Cancer Have Lower Chance of Receiving Immunotherapy

Japan-developed liver cancer screening system to be introduced in Thailand

Etiologies of Liver Cancer are Changing and the Prognosis is Mixed, Study Says

Liver Cancer Symptoms: Lump In Right Side Of Stomach Could Be A Sign Of The Disease

Doctors Transplant Damaged Liver After Treating It for Three Days

Researchers Identify Possible Liver Cancer Immunotherapy

Radiation Segmentectomy Efficacious for Unresectable Liver Cancer

CT Radiomics Helps Predict HCC Recurrence After Liver Transplant

AUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 FINANCING FOR NOVEL BIOELECTRIC CANCER TREATMENT PLATFORM

UTSW Researchers Identify a New Biomarker to Assess Your Risk of Liver Cancer

CStone Presents Updated Results of anti-PD-1 antibody Nofazinlimab in Combination with Lenvatinib as First-Line Treatment in Patients with Unresectable Hepatocellular Carcinoma (HCC) at ASCO 2022

Diagnosing Liver Diseases: New Review Presents Non-Invasive Methods for Better Accuracy

Endothelial Cell Signaling May Drive Liver Cancer Progression

May 2022

Eureka, City of Hope Begin Phase I/II Trial of T-Cell Therapy in GPC3-Positive Liver Cancer

How Have Hepatocellular Carcinoma Treatments Improved?

Multiple-Target Blood Test Detects Liver Cancer After Cirrhosis

Scientists Discover New Clues to Liver Cancer Progression

A New High-Risk Subtype of Pediatric Liver Cancer Identified

Video: How Lasers Can Track the Spread of Cancer

Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting

Combinations Gain Momentum as First-Line Treatments for Unresectable Hepatocellular Carcinoma

Amit Singal, MD: Role of Biomarkers in HCC Risk Stratification, Screening

GE Healthcare Signs up to Distribute HistoSonics' Soundwave Therapy for Liver Cancer

Post-Treatment Liver Stiffness Predicts Complications, HCC in Hepatitis C

Researchers Discover Effective Combination Immunotherapy for Liver Cancer

Researchers Halt Cancer with Sound, Human Trials Underway

‘Tecentriq-Avastin Combo Therapy Winner as First-line Treatment for Hepatocellular Carcinoma’

Aspirin and Statin Combination Therapy Linked to Lower Risk for HCC

TriSalus Enrols First Subject in Study of Liver Cancer Treatment Using Pressure-enabled Drug Delivery

A Prospective Observational Cohort Study of Lenvatinib as Initial Treatment in Patients with BCLC-Defined Stage B Hepatocellular Carcinoma

How Accurate are Magnetic Resonance Imaging (MRI) Scans for Detecting Liver Cancer?

Study Sheds Light on Abnormal Lipidome Accumulation in Hepatocellular Carcinoma

Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma

Support for Liver Cancer at ASCO 2022

Immunotherapy for kids: An option for childhood liver cancer?

Ultrasound as a Treatment for Liver Cancer Shows Promise

Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit

April 2022

Dudeja Receives a $2 Million Grant from the Department of Defense to Research Liver Cancer

Hep C Without Symptoms? You Still Need to Get Treated

Cellular regeneration therapy restores damaged liver tissue faster than ever

MAIA Biotechnology, Inc. Announces FDA Orphan Drug Designation for THIO for the Treatment of Hepatocellular Carcinoma (HCC)

AstraZeneca Moves Toward Approval of CTLA-4 Antibody Combo for HCC

Tremelimumab Accepted Under Priority Review in the US for Patients with Unresectable Liver Cancer in Combination with Imfinzi

Biomarkers Over Biopsies: A Highly Accurate and Minimally Invasive Test for Liver Fibrosis

Non-Invasive Treatment Proven Effective for Rats with Liver Cancer

Unmet Needs in the Treatment of Advanced HCC in Second-Line and Beyond

How the Potential Use of Immunotherapy in Intermediate HCC Might Affect its Use in Advanced HCC

New Cancer Diet Studies Confirm Effects of Veggies and Red Meat

Rash in the Stomach is a Symptom of Liver Cancer, Avoid Eating These Things

Genome-wide Screening Identified Novel Targets for Treating Sorafenib-Resistant Hepatocellular Carcinoma

Tumors Partially Destroyed With Sound Don't Come Back

Nanotherapeutics for Hepatocellular Carcinoma Treatment

Korean, US Researchers Establish Genomic Subtypes of Liver Cancer

Exelixis Throws in the Towel on Early-Stage Liver Cancer After Final Readout Shows OS Flop

Liver cancer, the University of Trieste Identifies a New Therapeutic Approach – Medicine

Surface Oncology Announces Initiation of Phase 2 Studies Evaluating SRF388 in Patients with Hepatocellular Carcinoma and Non-Small-Cell Lung Cancer

Captor Therapeutics Announces Molecular Targets of CT-01 Program Developing TPD Therapy for Hepatocellular Carcinoma

Ex-Vivo: Improving Donated Livers and Saving Lives

Benefits and Risks of Living-Donor Liver Transplant

Cytovia Therapeutics Reports Preclinical Activity of its iPSC-derived NK (iNK) Cells and Flex-NK™ Cell Engagers at the 2022 AACR Annual Meeting

Blue Faery Gives Liver Cancer Research Award

Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review

Anti-Angiogenic Therapies in Second-Line and Beyond in Advanced HCC

Immunotherapies in Second-Line and Beyond in Advanced HCC

A Multi-analyte Cell-free DNA–based Blood Test for Early Detection of Hepatocellular Carcinoma

Statin Initiation Reduces Risk for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Illinois Cancer Center Develops Technology Identifying Early-Stage Liver Cancer

Opdivo-Yervoy Combo Treatment May Prolong Survival Without Disease Progression in Subgroup of Patients With Resectable Liver Cancer

New Liver Cancer Treatment ‘Effective in 90% of Patients’

Medical Robot Performs Minimally Invasive Liver Cancer Treatment

March 2022

U of I researchers develop new test to detect liver cancer

Mursla Gains Mentorship Support From Roche Diagnostics Ltd for Pilot Study in Cirrhotic and Liver Cancer Patients

Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?

Egypt's Health Ministry launches initiative to treat Hepatocellular carcinoma patients

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma

Recruitment for liver cancer detection study nears completion

Risk of Hepatocellular Carcinoma Recurrence After Hepatectomy Higher in Men Than Women

Sequencing of Drug Combinations Could Amplify Antitumor Immune Response in Liver Cancer

Frontline Therapies in Advanced HCC for Patients Unsuitable for Atezolizumab-Bevacizumab

Characteristics of Nonalcoholic Fatty Liver Disease–Related HCC vs HCC From Other Causes

FDA Clears Quantum Surgical’s Robot-Assisted Tumor Ablation Tech

Heavy Alcohol use Increases Liver Impairment, Risk for HCC in Hepatitis-Induced Cirrhosis

Cancer: Shoulder Pain Could be Caused by a Tumour Pressing Against the Liver - How to Tell

NAFLD Linked to Lower Early-Stage Detection, Poorer Survival in Patients with HCC

U.S. FDA Approves new Bristol Myers Cancer Immunotherapy

Perioperative Opdivo Alone, in Combination with Yervoy Safe in Patients with HCC

KNUH Team Offers Ways to Overcome Resistance to Liver Cancer Drug

Priming the Tumor Environment to Improve Efficacy of Existing Therapeutics for Liver Cancer

Tremelimumab/Durvalumab Combo Promising for Unresectable HCC

Perioperative Cemiplimab Shows Clinical Activity Among Patients With Early-Stage Hepatocellular Carcinoma

Frontline Cabozantinib/Atezolizumab Does Not Improve OS Over Sorafenib in Advanced HCC

Sequencing of Drug Combinations Could Amplify the Anti-Tumor Immune Response in Liver Cancer

Exelixis Throws in the Towel on Early-Stage Liver Cancer After Final Readout Shows OS flop

Can-Fite: Namodenoson’s Treatment of Liver Fibrosis Receives Notice of Allowance from U.S. Patent Office

Bristol Myers Squibb Nivolumab Marketing Approval to be Revoked for Hepatocellular Carcinoma : CDSCO Panel

Exelixis Announces Final Overall Survival Results from Phase 3 COSMIC-312 Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Patients with Previously Untreated Advanced Liver Cancer

Can-Fite’s Findings in the Treatment of Liver Diseases with Cannabinoids to be Presented at CannX Medical Cannabis Conference in Tel Aviv

Here's What Liver Cancer Feels Like, Say Physicians

Helio publishes study of HelioLiver cancer test

Bots Boost Liver Cancer Outcome

SSM Health Medical Minute: Liver Cancer Patients Have Closer Option for Treatment

First-Line Systemic Treatment for Advanced HCC

Patients Prioritize Higher Imaging Sensitivity Over Lower Costs When Weighing HCC Screening Options

Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer

GlycoPath Inc. Receives Prestigious Grant from the National Cancer Institute

Drug Combo Ups Ulcer Risk After Cryoablation in Patients With HCC

World Leaders Celebrate Liver Disease Successes, Prepare for Challenges Ahead

Did Pfizer mRNA Vaccine Combine With DNA In Liver Cells?!

Spots on the palms could be sign of liver cancer: doctor

AGA develops clinical practice guidelines on systemic therapy for HCC

Ghassan K. Abou-Alfa, MD, Details Survival Data With Durvalumab Plus Tremelimumab in HCC From HIMALAYA Trial

Liver disease: Stages, Symptoms, Lifestyle Changes to Adapt and Prevent It

NC-MRI Has High Sensitivity And an Acceptable Negative Likelihood Ratio Of HCC Detection: Study

February 2022

New Guidelines Clarify Use Of Systemic Therapy In Advanced HCC

New Clinical Trial Of A Non-Invasive Liver Cancer Treatment Set To Commence

Expert: Patients With Cirrhosis Have A ‘Sufficiently High Risk’ For Liver Cancer

AGA Recommends Shared Decision-Making Approach For Treatment Of Hepatocellular Carcinoma (HCC)

Targeting Cancer: Patient Thriving Two Years After Terminal Liver Cancer Diagnosis

Award-Winning Singer And Songwriter Maranda Curtis Joins Forces With Blue Faery To Fight Liver Cancer

Doctoral Student Studying Liver Cancer Earns Prestigious Fellowship

FDA Grants Orphan Drug Designation To T-Cell Therapies For Advanced Liver Cancer

Ghassan K. Abou-Alfa, MD, Discusses Patient Population And Dosing For HCC In HIMALAYA Trial

ASTRO Offers Guidance On EBRT For Primary Liver Cancers

The Blue Faery “Love Your Liver” Public Awareness Campaign

Liver Cirrhosis Has Higher Hospitalization And In-Hospital Mortality Rates In Germany

Vaccines For Cancer Are Already Here – And You Can Get Them

Prevention Of Liver Cancer

Tremelimumab/Durvalumab Combo Promising For Unresectable HCC

Liver Cancer In Hispanic And Latino Communities: What You Need To Know

Biomarkers In Saliva May Detect Hepatocellular Carcinoma

Researchers Restore Function In A Gene That Can Suppress Liver Cancer And Enhance Immunotherapy

Antihistamines May Reduce Risk Of Hepatocellular Carcinoma In Patients With Viral Hepatitis

Cutting Off Liver Cancer’s Nutrient Supply Chain

Study Assesses Real-World Outcomes Of Immunotherapy In Patients With HCC, Comorbidities

Study Of A Tremelimumab-Imfinzi Combination May Lead To New Liver Cancer Treatment Strategy

VIDEO: Use Of Radiation Therapy As A Bridge-To-Transplant In Liver Cancer

January 2022

Cemiplimab Promises To Be Effective Against Resectable Liver Cancer

Researchers Develop New Tool To Determine Patients' Liver Cancer Risk After Hepatitis C

Georgia Cancer Center Researcher Works To Develop New Treatment Options For Liver Cancer

Innovent, Lilly Report Phase Ib Sintilimab Data In Hepatocellular Carcinoma

90K People Receive Medical Services Within Early Detection Of Liver Cancer Programme

Stride Regimen Extends Survival In Unresectable Hepatocellular Carcinoma

Minimally Invasive Procedure Combined With Lenvima And Checkpoint Blockade Shows Promise In Unresectable Liver Cancer

Libtayo Effective In Killing HCC Tumors Prior To Resection

Merck's Keytruda Narrowly Passes Liver Cancer Confirmatory Trial, But Murky Fda Fate Lies Ahead

Optical Biopsy System Cuts Potential For Misdiagnoses Of Liver Cancer

Researchers Identify Novel Pathways Responsible For Liver Cancer

Durvalumab Plus Tremelimumab Improves Os In Unresectable HCC

Phase 3 Data For Pembrolizumab In Hepatocellular Carcinoma Show Significant Improvements

Surefire Ways To Protect Your Liver

Research In Oklahoma City Could Be A Game-Changer For Thousands On Liver Transplant List

Scientists Discover Cytochrome P450 Family Member Cyp39a1 Can Block Hepatocarcinogenesis

RNA Discovery May Lead To Better Diagnosis And Treatment Of Liver Cancer

Liver Cancer: The Warning Sign Under Your Ribs And 16 Other Symptoms Of The Disease

Can Non-Invasive Medical Devices Help Halt Liver Disease?

New Guidance In Place To Lower Incidence Of Liver Cancer

Dr. Khushman On Best Practices In The Management Of GI Cancers

Knight Therapeutics Inc. Announces Approval Of Lenvima® In Colombia

Microwave Ablation Performed To Treat Liver Cancer

First-Line Nivolumab Does Not Improve Survival In Advanced Hepatocellular Carcinoma

FDA Grants Fast Track Designation To Tcr T-Cell Therapy For Hepatocellular Carcinoma

Dr. Manne On The Need For Novel Therapies In HCC Without Preserved Liver Function

Unresectable HCC: Interpreting Data From The Imbrave150 Trial

Defining The Role Of Adjuvant Therapy For HCC

Case 3: A Patient With Metastatic HCC